GME
88
5
CMCSA
52
4
AKAM
42
2
VRSN
58
8
GOOG
65
-2
MSFT
58
4
KR
65
-3
SLB
44
2
HCA
53
-6
NWSA
78
3
CF
53
2
KEY
48
-12
SHW
61
11
COP
39
2
IPG
48
6
MS
69
3
WYNN
36
2
EMC
73
3
EMN
53
-7
DAL
46
2
GME
88
5
CMCSA
52
4
AKAM
42
2
VRSN
58
8
GOOG
65
-2
MSFT
58
4
KR
65
-3
SLB
44
2
HCA
53
-6
NWSA
78
3
CF
53
2
KEY
48
-12
SHW
61
11
COP
39
2
IPG
48
6
MS
69
3
WYNN
36
2
EMC
73
3
EMN
53
-7
DAL
46
2
Financhill
Back

Charles River Laboratories International 10K Form

Sell
34

CRL
Charles River Laboratories International

Last Price:
$114.68
Seasonality Move:
5.51%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2023-11-08 10Q CRL/Charles River Laboratories International Quarterly
2023-08-09 10Q CRL/Charles River Laboratories International Quarterly
2023-05-11 10Q CRL/Charles River Laboratories International Quarterly
2022-11-02 10Q CRL/Charles River Laboratories International Quarterly
2022-08-03 10Q CRL/Charles River Laboratories International Quarterly
2022-05-04 10Q CRL/Charles River Laboratories International Quarterly

Receive CRL News And Ratings

See the #1 stock for the next 7 days that we like better than CRL

CRL Financial Statistics

Sales & Book Value

Annual Sales: $4B
Cash Flow: $83.7M
Price / Cash Flow: 11.81
Annual Sales: $67.69
Price / Book: 1.69

Profitability

EPS (TTM): 0.15000
Net Income (TTM): $22.2M
Gross Margin: $1.3B
Return on Equity: 0.6%
Return on Assets: 0.28%

Charles River Laboratories International Earnings Forecast

Key Charles River Laboratories International Financial Ratios

  • The Gross Profit Margin over the past 27 years for CRL is 32.88%.
  • The Selling, General & Administrative Expenses for CRL have been equal to 18.54% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 568.79% of Operating Income.
  • The Net Earning history of CRL is 0.55% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Charles River Laboratories International Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: CRL
CUSIP: 159864
Website: criver.com

Debt

Debt-to-Equity Ratio: 0.65
Current Ratio: 1.41
Quick Ratio: 0.92

Price-to-Earnings

Trailing P/E Ratio: 573.3
Forward P/E Ratio: 11.38

CRL Technical Analysis vs Fundamental Analysis

Sell
34
Charles River Laboratories International (CRL) is a Sell

Is Charles River Laboratories International a Buy or a Sell?